Business
Single-shot Johnson & Johnson vaccine ‘highly effective’ in preventing severe COVID-19 – SBS News
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa,…
The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administration.
The news on Wednesday came as the US regulator was set to convene an independent panel Friday that will likely vote to authorise the vaccine, making it the third available in the country hit hardest by the coronavirus pandemic.
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe…
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business24 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Business23 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy